Skip to content
Austin Top 50
Author:
Femasys Inc.
Femasys Doubles Enrolling Sites in FemBloc FINALE Pivotal Trial for Non-Surgical Permanent Birth Control
October 16, 2026
Femasys to Exhibit at the ASRM 2026 Scientific Congress & Expo
October 13, 2026
Femasys Advances OB/GYN Expansion with Adoption of FemaSeed® Fertility Portfolio by Minnesota Women’s Care
September 15, 2026
Femasys Partners with CapexMD to Expand Patient Access to FemaSeed® Fertility Portfolio
September 9, 2026
Femasys Partners with UNC Health to Introduce Its FemaSeed® Fertility Portfolio Across Statewide OB/GYN Care Locations
August 26, 2026
Femasys Enables OB/GYNs to Deliver First-Line Fertility Treatment with Initial Commercial Use of FemaSeed® Complete
May 7, 2026
Femasys Launches FemaSeed® Complete for OB/GYNs at ACOG 2026
April 24, 2026
Femasys Advances FemBloc Toward U.S. Approval with Initiation of Pivotal Trial Enrollment
March 10, 2026